Gland Pharma Ltd Quarterly Results

Gross Sales

1,486.88

1,505.62

1,424.91

1,384.05

1,405.83

Excise Duty

0

0

0

0

0

Net Sales

1,486.88

1,505.62

1,424.91

1,384.05

1,405.83

Other Operating Income

0

0

0

0

0

Other Income

84.16

57.53

44.03

58.49

59.66

Total Income

1,571.04

1,563.15

1,468.94

1,442.55

1,465.49

Total Expenditure

1,172.99

1,137.86

1,077.39

1,024.1

1,108.78

PBIDT

398.05

425.29

391.54

418.45

356.72

Interest

7.82

11.5

7.45

22.82

6.11

PBDT

390.23

413.79

384.09

395.63

350.6

Depreciation

106.31

101.05

95.76

96.33

93.83

Minority Interest Before NP

0

0

0

0

0

Tax

103.84

102

103.74

94.54

95.9

Deferred Tax

-3.61

-4.74

-1.95

0.07

-2.66

Reported Profit After Tax

183.68

215.48

186.54

204.69

163.53

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

183.68

215.48

186.54

204.69

163.53

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

183.68

215.48

186.54

204.69

163.53

EPS (Unit Curr.)

11.15

13.08

11.32

12.42

9.93

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

16.48

16.48

16.48

16.48

16.48

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

26.77

28.24

27.47

30.23

25.37

PBDTM(%)

26.24

27.48

26.95

28.58

24.93

PATM(%)

12.35

14.31

13.09

14.78

11.63